Immune Tolerance
Showing 1 - 25 of >10,000
Immune Tolerance Breakdown in HU-autoimmunity
Active, not recruiting
- Immune Tolerance
- Description of clinical, immunological and tumor features of patients harboring Hu Abs
-
Lyon, FranceCentre de référence des syndromes neurologiques paranéoplasiques
Feb 23, 2023
Tolerance in Beekeepers
Not yet recruiting
- Bee Sting
- skin prick test
- Blood tests
- (no location specified)
Nov 24, 2023
Immune Tolerance After Pediatric Liver Transplantation
Recruiting
- Immune Tolerance
- Liver Transplant; Complications
- IS weaning off
-
Shanghai, Shanghai, ChinaRen Ji Hospital affiliated to Shanghai Jiao Tong University Scho
Aug 11, 2022
Immune Tolerance, Immunosuppression, Liver Transplant; Complications Trial in Tianjin (Tacrolimus or Cyclosporine A)
Not yet recruiting
- Immune Tolerance
- +2 more
- Tacrolimus or Cyclosporine A
-
Tianjin, Tianjin, ChinaTianjin First Central Hospital
Nov 23, 2023
Immune Tolerance Dysfunction in Pregnancy Due to Ambient Air
Active, not recruiting
- Air Pollution
- Pregnancy
- There is no intervention
-
Palo Alto, CaliforniaSean N. Parker Center for Allergy & Asthma Research at Stanford
Nov 22, 2022
Hemophilia A With Inhibitor Trial (SCT800 and Daratumumab)
Not yet recruiting
- Hemophilia A With Inhibitor
- SCT800 and Daratumumab
- (no location specified)
May 24, 2023
Kidney Transplant Rejection Trial (MDR-103)
Not yet recruiting
- Kidney Transplant Rejection
- MDR-103
- (no location specified)
Apr 4, 2022
Immunosuppression, Immune Tolerance Trial in Toronto (Controlled weaning of immunosuppression)
Completed
- Immunosuppression
- Immune Tolerance
- Controlled weaning of immunosuppression
-
Toronto, Ontario, CanadaToronto General Hospital
Sep 29, 2021
Vitamin D in Recurrent Spontaneous Abortion
Completed
- Vitamin D Deficiency
- Recurrent Spontaneous Abortion
- Binom Vitamin D drops
-
Hangzhou, Zhejiang, ChinaJianmei Xia
Aug 17, 2023
Type 2 Diabetes, Diabetes, Type 2, Renal Transplant Trial in London (AZD1656, Placebo)
Recruiting
- Type 2 Diabetes
- +4 more
- AZD1656
- Placebo
-
London, United KingdomRoyal London Hospital Barts Health NHS Trust
Feb 4, 2022
Pompe Disease, Glycogen Storage Disease Type II (GSD-II), Glycogenesis 2 Acid Maltase Deficiency Trial in Israel, United States
Terminated
- Pompe Disease
- +2 more
- Myozyme® (alglucosidase alfa)
-
Louisville, Kentucky
- +4 more
Mar 24, 2022
Follow up of LEAP Participants and Their Families
Completed
- Peanut Allergy
-
London, United KingdomEvelina London Children's Hospital
Nov 30, 2022
Liver Transplant, Liver Transplantation Trial in United States (Immunosuppression withdrawal)
Completed
- Liver Transplant
- Liver Transplantation
- Immunosuppression withdrawal
-
San Francisco, California
- +6 more
Aug 10, 2022
Immune Tolerance, Viral Infection Trial in Singapore (Reduxium)
Completed
- Immune Tolerance
- Viral Infection
- Reduxium
-
Singapore, Singapore
- +2 more
May 26, 2022
Hemophilia A Trial in Worldwide (Recombinant coagulation factor (rFVIIIFc))
Completed
- Hemophilia A
- Recombinant coagulation factor (rFVIIIFc)
-
Washington, District of Columbia
- +11 more
Feb 21, 2022
Liver Transplant Trial in Boston (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg-CSB
- +4 more
-
Boston, MassachusettsMassachusetts General Hospital: Transplantation
Jan 30, 2023
Allergic Rhinoconjunctivitis, Grass Pollen Allergy Trial in London (Dupixent®, Grazax®, Dupixent® Placebo)
Recruiting
- Allergic Rhinoconjunctivitis
- Grass Pollen Allergy
- Dupixent®
- +3 more
-
London, United KingdomRoyal Brompton Hospital
Jul 5, 2022
Allergic Diseases, Asthma Trial in New York (biological, drug, other)
Recruiting
- Allergic Diseases
- Asthma
- C-section -Vaginal seeding
- +2 more
-
New York, New York
- +1 more
Sep 28, 2022
Immunological Reaction of Seminal Fluid in Mother's Blood and
Recruiting
- Preeclampsia
- +4 more
-
Ramat Gan, Israel
- +1 more
May 4, 2022
Severe Hemophilia A Trial in Duarte (VWF/FVIII concentrates)
Completed
- Severe Hemophilia A
- VWF/FVIII concentrates
-
Duarte, CaliforniaCity of Hope Medical Center
Aug 18, 2021
Recipients Who Previously Received Medeor's Cellular
Recruiting
- Immune Tolerance
- MDR product
-
New Haven, ConnecticutYale University
Apr 18, 2022
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
Solid Tumor Trial (LM103)
Not yet recruiting
- Solid Tumor
- LM103
- (no location specified)
Jul 25, 2023
ESRD Trial in Stanford, Madison (Immune Tolerance)
Active, not recruiting
- ESRD
- Immune Tolerance
-
Stanford, California
- +1 more
Jun 30, 2022
Liver Transplant Trial in San Francisco (biological, procedure, drug)
Recruiting
- Liver Transplant
- arTreg
- +4 more
-
San Francisco, CaliforniaUniversity of California, San Francisco
Sep 13, 2022